XML 66 R55.htm IDEA: XBRL DOCUMENT v3.8.0.1
SHAREHOLDERS' EQUITY (Details)
3 Months Ended 12 Months Ended 77 Months Ended
Jan. 31, 2018
shares
Jan. 30, 2018
$ / shares
Jan. 17, 2017
USD ($)
shares
Jul. 14, 2016
USD ($)
Jan. 29, 2016
shares
Dec. 10, 2013
USD ($)
shares
Dec. 31, 2017
USD ($)
senior_executive
$ / shares
shares
Sep. 30, 2017
$ / shares
Jun. 30, 2017
$ / shares
Mar. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
Sep. 30, 2017
$ / shares
Dec. 31, 2017
USD ($)
$ / shares
shares
Oct. 02, 2017
Aug. 31, 2016
USD ($)
Aug. 03, 2016
USD ($)
Mar. 31, 2016
USD ($)
Sep. 30, 2015
USD ($)
Feb. 27, 2014
USD ($)
Dec. 21, 2009
USD ($)
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Common stock, dividends, per share, cash paid (in Dollars per share) | $ / shares             $ 0.07 $ 0.06 $ 0.07 $ 0.06 $ 0.06 $ 0.24                
Share-based compensation arrangement by share-based payment award, description             Options granted under the Incentive Plan may be either “incentive stock options” or nonqualified stock options, generally expire ten years after the date of grant and are granted at an exercise price of not less than 100% of the fair market value at the date of grant.                          
Share-based compensation arrangement by share-based payment award, expiration period             10 years                          
Maximum percentage of exercise price at grand date fair value             100.00%                          
Stock-based compensation | $             $ 2,555,000       $ 2,452,000                  
Shares paid for tax withholding for share based compensation (in Shares)             191,332                          
Shares paid for tax withholding for share based compensation, value | $             $ 4,332,000                          
Shares paid for tax withholding for share based compensation, value per share (in Dollars per share) | $ / shares             $ 22.64                          
Face amount | $                             $ 35,092,000   $ 8,000,000 $ 32,280,000    
Stock repurchase program, authorized amount | $           $ 50,000,000                   $ 50,000,000        
Stock repurchase program, remaining authorized repurchase amount | $             $ 49,437,000           $ 49,437,000              
Stock repurchased during period (in shares)           4,444,444             15,984,854              
Stock repurchased during period, value | $                         $ 211,621,000              
Stock repurchased during period per share (in Dollars per share) | $ / shares                         $ 13.24              
Remaining number of shares authorized to be repurchased           5,555,556,000                            
Incentive Stock Options [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Number of shares available for grant (in Shares)             305,512           305,512              
2006 Equity Incentive Plan [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Share based compensation arrangement by share based payment award equity instruments other than options additional grants in future (in Shares)             0           0              
Restricted Stock and Restricted Stock Units [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Equity instruments other than options, grants in period (in Shares)             1,008,756                          
Performance Shares [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Award vesting period             3 years                          
Equity instruments other than options, grants in period (in Shares)             480,756                          
Equity instruments other than options, vested in period, fair value | $             $ 9,980,000                          
Equity instruments other than options, grants in period, weighted average grant date fair value (in Dollars per share) | $ / shares             $ 20.76                          
Restricted Stock and Performance Shares [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Equity instruments other than options, grants in period (in Shares)             528,000                          
Minimum [Member] | Restricted Stock [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Award vesting period             3 years                          
Maximum [Member] | Restricted Stock [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Award vesting period             4 years                          
Executive Officer [Member] | Restricted Stock [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Award vesting period             4 years                          
Equity instruments other than options, vested in period, fair value | $                   $ 7,008,000                    
Equity instruments other than options, grants in period, weighted average grant date fair value (in Dollars per share) | $ / shares                   $ 13.27                    
Number of persons granted shares | senior_executive             2                          
Award post-vesting holding period             2 years                          
Executive Officer [Member] | Minimum [Member] | Restricted Stock [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Awards vested in period (in shares)                   384,000                    
Executive Officer [Member] | Maximum [Member] | Restricted Stock [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Awards vested in period (in shares)                   528,000                    
Convert. debt due 2017 [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Face amount | $                                       $ 100,000,000
Debt instrument, interest rate, stated percentage                                       4.00%
Senior Notes 2022 [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Face amount | $                                     $ 600,000,000  
Debt instrument, interest rate, stated percentage                           5.25%         5.25%  
Debt conversion, original debt, amount | $       $ 125,000,000                                
Convertible Notes 2017 [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Debt conversion, converted instrument, amount | $     $ 173,855,000             $ 173,855,000                    
Debt conversion, converted instrument, cash received | $     125,000,000             $ 125,000,000                    
Issuance of treasury stock in settlement of convertible debt | $     $ 48,858,000                                  
Debt conversion, converted instrument, shares issued     1,954,993             1,954,993                    
Subsequent Event [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Dividends declared, amount per share (in Dollars per share) | $ / shares   $ 0.07                                    
Subsequent Event [Member] | Incentive Stock Options [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Number of shares available for grant (in Shares) 1,260,622                                      
Subsequent Event [Member] | Restricted Stock and Performance Shares [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Equity instruments other than options, grants in period (in Shares) 44,890,000                                      
Incentive Plan [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Number of shares authorized for award (in Shares)         3,350,000                              
New shares issued (in Shares)         600,000                              
Incentive Plan [Member] | Subsequent Event [Member]                                        
SHAREHOLDERS' EQUITY (Details) [Line Items]                                        
Number of shares authorized for award (in Shares) 1,000,000